Evidence map›Paper›PMID 36298798›Full record

ArticleViruses2022

Increased CD4

Huiyuan Zhang, Yazhen Wang, Ying Ma, Kang Tang, Chunmei Zhang, Meng Wang, Xiyue Zhang, Manling Xue, Xiaozhou Jia, Haifeng Hu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. CD4Frontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Huiyuan ZhangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yazhen WangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Ying MaDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Kang TangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.ORCID 0000-0002-6756-0219
Chunmei ZhangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Meng WangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Xiyue ZhangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Manling XueDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Xiaozhou JiaEighth Hospital of Xi'an, Xi'an 710061, China.
Haifeng HuCenter for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Na LiDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Ran ZhuangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.ORCID 0000-0002-3614-0422
Boquan JinDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Lihua ChenDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yun ZhangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yusi ZhangDepartment of Immunology, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.ORCID 0000-0003-4272-857X
Air Force Medical University · CNYan'an University · CNTang Du Hospital · CNThe Eighth Hospital of Xi'an · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hantaan virus (HTNV) infection causes an epidemic of hemorrhagic fever with renal syndrome (HFRS) mainly in Asia. It is well known that T cells mediated anti-viral immune response. Although previous studies showed that double positive T (DP T) cells, a little portion of T lymphocytes, were involved in adaptive immune response during virus infection, their kinetic changes and roles in HTNV infection have not yet been explored. In this study, we characterized DP T cells from HFRS patients based on flow cytometry data combined with scRNA-seq data. We showed that HTNV infection caused the upregulation of DP T cells in the peripheral blood, which were correlated with disease stage. The scRNA-seq data clustered DP T cells, unraveled their gene expression profile, and estimated the ordering of these cells. The production of granzyme B and CD107a from DP T cells and the abundant TCR distribution indicated the anti-viral property of DP T cells. In conclusion, this study identified, for the first time, an accumulation of DP T cells in the peripheral blood of HFRS patients and suggested these DP T cells belonging to CD8

Indexed as

Hantaan virusHantavirus InfectionsHemorrhagic Fever with Renal SyndromeCD8-Positive T-LymphocytesGranzymesHumansReceptors, Antigen, T-CellGranzymesReceptors, Antigen, T-CellCD8DP T cellsHFRSHTNV

Identifiers

PMID36298798
PMCPMC9611689
OpenAlexW4306160754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.